Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016

In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Soeters, Heidi M., Dinitz-Sklar, Jill, Kulkarni, Prathit A., MacNeil, Jessica R., McNamara, Lucy A., Zaremski, Elizabeth, Chang, How-yi, Lujan, Eduardo, Granoff, Dan, Lasky, Melodee, Montana, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403061/
https://www.ncbi.nlm.nih.gov/pubmed/28418307
http://dx.doi.org/10.3201/eid2305.161870
Descripción
Sumario:In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic data to inform real-time response.

Ejemplares similares